Pulsenmore Ltd. Ordinary Shares (PLSM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pulsenmore Ltd. Ordinary Shares (PLSM) has a cash flow conversion efficiency ratio of -0.344x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-28.56 Million) by net assets ($83.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Pulsenmore Ltd. Ordinary Shares to measure how many days the company can operate on defensive assets alone.
Pulsenmore Ltd. Ordinary Shares - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Pulsenmore Ltd. Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Pulsenmore Ltd. Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pulsenmore Ltd. Ordinary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Acco Group Holdings Limited Ordinary Shares
NASDAQ:ACCL
|
-0.123x |
|
Phatra Leasing Public Company Limited
BK:PL
|
0.065x |
|
Kingston Resources Ltd
AU:KSN
|
0.081x |
|
Lyckegard Group AB
ST:LYGRD
|
-0.215x |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
0.134x |
|
Axteria Group Bhd
KLSE:7120
|
-0.024x |
|
WOLFTANK-ADISA HLDG O.N.
F:WAH
|
N/A |
|
KBC Global Limited
NSE:KBCGLOBAL
|
0.000x |
Annual Cash Flow Conversion Efficiency for Pulsenmore Ltd. Ordinary Shares (2019–2025)
The table below shows the annual cash flow conversion efficiency of Pulsenmore Ltd. Ordinary Shares from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Pulsenmore Ltd. Ordinary Shares worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $83.09 Million | $-32.88 Million | -0.396x | -21.06% |
| 2024-12-31 | $103.15 Million | $-33.71 Million | -0.327x | -0.64% |
| 2023-12-31 | $130.70 Million | $-42.45 Million | -0.325x | -142.08% |
| 2022-12-31 | $182.67 Million | $-24.51 Million | -0.134x | +17.85% |
| 2021-12-31 | $159.28 Million | $-26.01 Million | -0.163x | +90.90% |
| 2020-12-31 | $5.28 Million | $-9.47 Million | -1.794x | -85.34% |
| 2019-12-31 | $3.95 Million | $-3.83 Million | -0.968x | -- |
About Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.